SCHEMBL29520292

SCHEMBL29520292

CC(C)=C1C(c2cccc(C)c2)=NC(C(C)(C)C)=Nc2ccccc21

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 3/20 0.35
CNR2 P34972 3/20 0.35
MAPT P10636 4/20 0.35
THRB P10828 1/20 0.35
PDK2 Q15119 1/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 3/20 0.33
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
CHEK1 O14757 1/20 0.33
MAP4K4 O95819 1/20 0.33
ABL1 P00519 1/20 0.33
NTRK1 P04629 1/20 0.33
LCK P06239 1/20 0.33
FYN P06241 1/20 0.33
CSF1R P07333 1/20 0.33
MET P08581 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29520620 0.86 CNR1 (0.38) CNR1CNR2MAPTTHRBPDK2
SCHEMBL29520721 0.86 MEN1 (0.33) MAPTMEN1KMT2AKDM4EALDH1A1
SCHEMBL29409248 0.85 NPC1 (0.36) CNR1CNR2MAPTMEN1KMT2A
SCHEMBL29520737 0.84 IDO1 (0.40) MAPTMEN1KMT2AKDM4EALDH1A1
SCHEMBL29520545 0.84 MAPT (0.42) MAPTTHRBMEN1KMT2AKDM4E
SCHEMBL29520490 0.80 KDM4E (0.31) MAPTMEN1KMT2AKDM4EALDH1A1
SCHEMBL29520739 0.80 CNR1 (0.34) CNR1KDM4EALDH1A1NPC1RAB9A
SCHEMBL29520584 0.78 MAPT (0.38) MAPTPDK2MEN1KMT2AKDM4E
SCHEMBL29520342 0.76 MAPT (0.40) MAPTPDK2MEN1KMT2AKDM4E
SCHEMBL29520778 0.76 CHRM1 (0.37) MEN1KMT2AALDH1A1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112174901-B Synthesis method and anticancer activity of 1, 3-benzodiazepine compound 河南师范大学 2022-02-08 CN disclosed